Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

NCT06685354 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

11

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DRUG: hepatic arterial infusion of recombinant human type 5 adenovirus

Sponsor

Henan Cancer Hospital